Literature DB >> 1601009

Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

S Kobayashi1, N Wada, M Kubo.   

Abstract

Pathological studies have revealed that the vasculitis in Kawasaki disease (KD) begins in the intima and the adventitia of blood vessels resulting in panvasculitis. In the present study we investigated the possibility that auto-antibodies to types III and II collagen are involved in the vascular injury. Seven out of 38 patients (18%) with KD had elevated serum levels of IgG antibody to type III collagen. None had increased serum antibodies to type II collagen. Specificity of the antibody to type III collagen in patients with KD was 86%. Three out of seven KD patients (42.9%) with coronary complications had elevated serum levels of the antibody. It is conceivable that the more severe the inflammation of systemic blood vessels, the more frequently antibodies to type III collagen are detected and coronary complications develop. Accordingly, this antibody may be secondarily detected in the serum of KD when systemic blood vessels are severely damaged. Detection of antibodies to type III collagen might be a risk factor predicting coronary complications.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601009     DOI: 10.1007/bf01954380

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Circulating immune complexes in Kawasaki syndrome.

Authors:  W H Mason; S C Jordan; R Sakai; M Takahashi; B Bernstein
Journal:  Pediatr Infect Dis       Date:  1985 Jan-Feb

2.  [A study of immune complexes in Kawasaki disease].

Authors:  Y Yanase; T Kawasaki; S Yoshinoya; T Aikawa; Y Hashimoto; T Mitamura; Y Miyoshi; M Muranaka; T Miyamoto
Journal:  Arerugi       Date:  1984-01

3.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

4.  Possible polyclonal B cell activation in mucocutaneous lymph node syndrome.

Authors:  F Furukawa; G Ohshio; Y Hamashima
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  An improved enzyme-linked immunosorbent assay of anti-collagen antibodies in human serum.

Authors:  K Fujii; M Tsuji; K Murota; K Terato; Y Shimozuru; Y Nagai
Journal:  J Immunol Methods       Date:  1989-11-13       Impact factor: 2.303

6.  Variant strain of Propionibacterium acnes: a clue to the aetiology of Kawasaki disease.

Authors:  H Kato; T Fujimoto; O Inoue; M Kondo; Y Koga; S Yamamoto; M Shingu; K Tominaga; Y Sasaguri
Journal:  Lancet       Date:  1983-12-17       Impact factor: 79.321

7.  Kawasaki disease: monitoring of circulating immune complexes.

Authors:  E Salo; R Kekomäki; P Pelkonen; O Ruuskanen; M Viander; O Wagner
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

8.  Impaired granulocyte chemotaxis and increased circulating immune complexes in Kawasaki disease.

Authors:  S Ono; T Onimaru; K Kawakami; M Hokonohara; K Miyata
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

9.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

10.  Lymphocyte subpopulations in Kawasaki disease.

Authors:  K Shannon; C W Fink; G R Buchanan; M Punaro; P Stastny
Journal:  Clin Exp Rheumatol       Date:  1983 Jan-Mar       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.